Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens

Microbial Biotechnology

Volumn 4, Issue 5, 2011, Pages 643-650

  Kvachadze, Leila ^a   Balarjishvili, Nana ^a   Meskhi, Tamila ^a   Tevdoradze, Ekaterine ^a   Skhirtladze, Natia ^a   Pataridze, Tamila ^a   Adamia, Revaz ^a   Topuria, Temur ^b   Kutter, Elizabeth ^c   Rohde, Christine ^d   Kutateladze, Mzia ^a  

^a Laboratory of Genetic Engineering and Biotechnology   (United States)

^b Cystic Fibrosis National Center   (United States)

^c LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^d Evergreens State College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIOLYSIS; BACTERIUM ISOLATE; CLINICAL ASSESSMENT; CYSTIC FIBROSIS; GENOME; HOSPITAL; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; SEQUENCE ANALYSIS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS PHAGE;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BIOLOGICAL THERAPY; CHILD; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOME, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGES; VIRAL PROTEINS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 84860389517     PISSN: 17517907     EISSN: 17517915     Source Type: Journal    
DOI: 10.1111/j.1751-7915.2011.00259.x     Document Type: Article

References (32)

1. Ackermann, H.-W., and Abedon, S. (2001) Bacteriophage names 2000 [WWW document]. URL.
2. Adams, M. (1961) Bacteriophages. Moscow: Publishers of Foreign Literature.
3. Andriashvili, I., Kvachadze, L., Adamia, R., Tushishvili, D., Kalandarishvili, L., and Chanishvili, T. (1981) Characterization of primary and secondary structure of DNA of staphylococcal bacteriophage Sb-1.Questions in Virology 1: 100-103.
4. Andriashvili, I., Kvachadze, L., Vashakidze, R., Adamia, R., and Chanishvili, T. (1986) Molecular mechanism of DNA protection from restriction endonucleases in Staphylococcus aureus cells. Mol Gen Microbiol Virol 8: 43-45.
5. Ayliffe, G. (1997) The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 24: 74-79.
6. Barrow, P., and Soothill, J. (1997) Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol 7: 268-271.
7. Bruttin, A., and Brussow, H. (2005) Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother 49: 2874-2878.
8. Carlton, R.M. (1999) Phage therapy: past history and future prospects. Arch Immunol Ther Exp 5: 267-274.
9. Chambers, H. (1997) Methicillin resistance in Staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10: 781-791.
10. Chanishvili, N., and Sharp, R. (2008) Bacteriophage therapy: experience from the Eliava Institute, Georgia. Aust Microbiol 20: 96-101.
11. Chanishvili, N., Chanishvili, T., Tediashvili, M., and Barrow, P.A. (2001) Phages and their application against drug-resistant bacteria. J Chem Technol Biotechnol 76: 689-699.
12. Chibani-Chenooufi, S., Dilman, M., Marvin, L., Rami-Shojaei, S., and Brussow, H. (2004) Lactobacillus plantarum bacteriophage LP65: a new member of the SPO1-like genus of the family Myoviridae. J Bacteriol 186: 7069-7083.
13. Cosgrove, S., Sakoulas, G., Perencevich, E., Schwaber, M., Karchmer, A., and Carmeli, Y. (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36: 53-59.
14. Duckworth, D., and Gulig, P. (2002) Bacteriophages: potential treatment for bacterial infections. BioDrugs 16: 57-62.
15. Herold, B.C., Immergluck, L.C., Maranan, M.C., LAuderdale, D.S., Gaskin, R.E., Boyle-Vavra, S., etal. (1998) Community-acquired Methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279: 593-598.
16. Inal, J. (2003) Phage therapy: a reappraisal of bacteriophages as antibiotics. Arch Immunol Ther Exp (Warsz) 51: 237-244.
17. Kellenberger, E. (1962) Vegetative bacteriophage and maturation of virus particles. Adv Virus Res 8: 108-112.
18. Klumpp, J., Dorscht, J., Lurz, R., Bielmann, R., Wieland, M., Zimmer, M., etal. (2008) The terminally redundant, nonpermuted genome of Listeria bacteriophage A511: a model for the SPO1-like Myoviruses of Gram-positive bacteria. J Bacteriol 190: 5753-5765.
19. Kutateladze, M., and Adamia, R. (2008) Phage therapy experience at the Eliava Institute. Med Mal Infect 38: 426-430.
20. Laemmli, U. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
21. Merril, C., Biswas, B., Carlton, R., Jensen, N., Creed, G., Zullo, S., and Adhya, S. (1996) Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci USA 8: 3188-3192.
22. Merril, C., Scholl, D., and Adhya, S. (2006) Phage therapy. In The Bacteriophages. Calendar, R. (ed.). Oxford, UK: University press, pp. 725-741.
23. Montensinos, I., Salido, E., Delgado, T., Cuervo, M., and Sierra, A. (2002) Epidemiologic genotyping of Methicillin-resistant Staphylococcus aureus by pulsed field gel electrophoresis at a university hospital and comparison with antibiotyping and protein A and coagulase gene polymorphisms. J Clin Microbiol 40: 2119-2125.
24. Mulvey, M., Chui, L., Ismail, J., Louie, L., Murphy, C., and Chang, M. (2001) Development a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed field electrophoresis. J Clin Microbiol 39: 3481-3485.
25. O'Flaherty, S., Coffey, A., Edwards, R., Meaney, W., Fitzgerald, J., and Ross, P. (2004) Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G-C content. J Bacteriol 186: 2862-2871.
26. Rees, P., and Fry, B. (1981) The morphology of staphylococcal bacteriophage K and DNA metabolism in infected Staphylococcus aureus. J Gen Virol 53: 293-307.
27. Stewart, C. (1993) SPO1 and related bacteriophages. In Bacillus subtilis and Other Gram-Positive Bacteria: Biochemistry, Physiology and Molecular Genetics. Soneshein, A.L., Hoch, J., and Losick, A. (eds). Washington DC, USA: ASM, pp. 813-829.
28. Stewart, C., Casjens, J.S., Cresawn, S., Houtz, J., Smith, A., Ford, M., etal. (2009) The genome of Bacillus subtilis bacteriophage SP01. J Mol Biol 388: 48-70.
29. Tenover, F., Arbeit, R., Goering, R., Mikelsen, P., Murray, B., Persing, D., and Swaminathan, B. (1995) Interpreting chromosomal DNA restriction patterns produced by PFGE: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
30. Tikhonenko, T. (1973) Biochemical Methods for Viruses. Moscow: Medicina.
31. Tikhonenko, T., Koudelka, I., and Borishpolets, Z. (1963) Concentration and purification of phages by column chromatography. J Microbiol 2: 723-727.
32. Yarwood, J., McCormick, J., Paustian, M., Orwin, P., Kapur, V., and Schlievert, P. (2002) Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. J Biol Chem 277: 13138-13147.